APLT - Applied Therapeutics GAAP EPS of -$0.37 August, 10 2023 12:25 PM Applied Therapeutics Inc. 2023-08-10 12:25:36 ET Applied Therapeutics press release ( NASDAQ: APLT ): Q2 GAAP EPS of -$0.37. Cash and cash equivalents and short-term investments totaled $35.6 million as of June 30, 2023, compared with $30.6 million at December 31, 2022. For further details see: Applied Therapeutics GAAP EPS of -$0.37